Katarina Luptakova
Chief Medical Officer at Xilio Therapeutics
Newtonville, Massachusetts, United States
Find your path to Katarina
Chief Medical Officer at Xilio Therapeutics
Intro paths
→
In turn, Katarina can intro founders to Xilio Therapeutics's investors below.
Xilio Therapeutics's investors · 15
Atlas VentureCambridge · $500K – $1M checks · since 2021Bain Capitalsince 2021Bain Capital Life SciencesBoston · since 2021Bay City CapitalSan Rafael · $5M – $10M checksDeerfield Management CompanyNew YorkF-Prime CapitalCambridge · $3M – $10M checks · since 2021M VenturesLos Angeles · $10.8M checksMRL Ventures FundCambridge · $25M checksRA CapitalBostonRiverVest Venture PartnersSt. Louis · $500K – $3M checksRock Springs CapitalBaltimoreSolasta VenturesBostonSV Health InvestorsBoston · $1M – $20M checksSV7 Impact MedicineLondonTakeda VenturesCambridge · $1M – $5M checks
Co-founders at Xilio Therapeutics
RR

René RussoExecutive Officer, Director
Experience
- Calytrix BioChief Medical Officercurrent2026 — present
- Xilio Therapeutics, Inc.Chief Medical Officer2023 — 2026Waltham, Massachusetts, United States
- Xilio Therapeutics, Inc.SVP, Medical2022 — 2023Waltham, Massachusetts, United States
- Xilio Therapeutics, Inc.VP, Clinical Research2021 — 2022
- Constellation PharmaceuticalsVP, Clinical Development2020 — 2021
- TESARO, Inc.Senior Medical Director, Clinical Research2018 — 2020
- TESARO, Inc.Medical Director, Clinical Research2017 — 2018Waltham, Massachusetts
- Takeda OncologyAssociate Medical Director/ Medical Director, Global Medical Affairs2015 — 2017
- Beth Israel Deaconess Medical CenterAttending physician in Hematologic Malignancies and Bone Marrow Transplant2011 — 2015
- Beth Israel Deaconess Medical CenterFellow in Hematology Oncology2008 — 2011
- Caritas St. Elizabeth's Medical CenterHospitalist2007 — 2008
- Caritas St. Elizabeth's Medical CenterChief Resident2006 — 2007
- Caritas St. Elizabeth's Medical CenterResident Physician2003 — 2006
- UMass Medical SchoolResearch Associate2001 — 2003
Skills & more
Oncology15Healthcare5Clinical Research8Transplant4Medical Education5Hematologic MalignanciesMedical AffairsWorking with Physicians3Hematology1Medicine2
From Katarina's professional profile.
Frequently asked questions
- Who is Katarina Luptakova?
- Chief Medical Officer at Xilio Therapeutics
- Where does Katarina Luptakova work?
- Katarina Luptakova is Chief Medical Officer at Xilio Therapeutics.
- Where did Katarina Luptakova go to school?
- Katarina Luptakova studied at Harvard Business School (Program for Leadership Development); Comenius University School of Medicine, Bratislava, Slovakia (Doctor of Medicine (MD)).
Same school
Also attended Harvard Business School2,000
Aileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at FloodgateNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of PayhawkVictoria TreygerGeneral Partner at Felicis Ventures
+ 1,994 more
Shared employers
Also worked at Xilio Therapeutics, Inc.8
Dan LynchInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesAlex Badamchi-ZadehVice President at SV Health InvestorsKeno GutierrezGeneral Partner at BioGeneration VenturesPeter DudekPresident at MRL Ventures FundUgur EskiocakFounder / EIR at 82VS
+ 2 more
Also worked at TESARO, Inc.2
Also worked at Takeda Oncology51
David SchenkeinInvestor at GV (Google Ventures)Kevin MunnellyInvestor at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesNeil ExterRetired Partner at Third Rock VenturesRobert TepperPartner and co-founder of Third Rock Ventures
+ 45 more
Also worked at Beth Israel Deaconess Medical Center57
Graham GardnerExecutive Partner at Flare Capital PartnersSun AltbachSenior Scientific Advisor at BOLD LongevityAndy BeckCEO, PathAI & Founding Pillar at Pillar VCDiane HessanSpecial Advisor at Data Point CapitalRichard StumacherClinical Advisor at Seae VenturesDanielle StrachmanInvestor at NZVC
+ 51 more




























